EOLS
Evolus Inc
Price:  
7.07 
USD
Volume:  
1,676,341.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-294.2%
Upside

As of 2025-12-22, the Relative Valuation of Evolus Inc (EOLS) is (13.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.07 USD, the upside of Evolus Inc based on Relative Valuation is -294.2%.

The range of the Relative Valuation is (10.06) - (14.53) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.2x - 16.1x 13.9x
Forward P/E multiples 11.1x - 18.6x 16.5x
Fair Price (10.06) - (14.53) (13.73)
Upside -242.4% - -305.5% -294.2%
7.07 USD
Stock Price
(13.73) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2025-12-19 -7.83
2025-12-18 -7.95
2025-12-17 -7.84
2025-12-16 -7.99
2025-12-15 -7.90
2025-12-12 -7.79
2025-12-11 -7.65
2025-12-10 -7.84
2025-12-09 -7.73
2025-12-08 -7.71
2025-12-05 -7.58
2025-12-04 -7.54
2025-12-03 -7.47
2025-12-02 -7.22
2025-12-01 -7.55
2025-11-28 -7.93
2025-11-26 -7.79
2025-11-25 -7.73
2025-11-24 -7.46
2025-11-21 -7.58
2025-11-20 -7.33
2025-11-19 -7.50
2025-11-18 -7.78
2025-11-17 -7.69
2025-11-14 -7.99
2025-11-13 -8.16
2025-11-12 -8.08
2025-11-11 -7.74
2025-11-10 -7.80
2025-11-07 -7.26
2025-11-06 -7.95
2025-11-05 -7.54
2025-11-04 -7.09
2025-11-03 -7.07
2025-10-31 -7.15
2025-10-30 -7.44
2025-10-29 -7.59
2025-10-28 -7.79
2025-10-27 -7.99
2025-10-24 -7.52
2025-10-23 -7.47
2025-10-22 -7.55
2025-10-21 -7.52
2025-10-20 -7.40
2025-10-17 -7.08
2025-10-16 -6.97
2025-10-15 -7.32
2025-10-14 -7.05
2025-10-13 -6.64
2025-10-10 -6.80